BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18328652)

  • 21. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat.
    Bhargava HN
    Gen Pharmacol; 1995 Sep; 26(5):1055-60. PubMed ID: 7557250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence.
    Suzuki S; Chuang LF; Doi RH; Bidlack JM; Chuang RY
    Int Immunopharmacol; 2001 Sep; 1(9-10):1733-42. PubMed ID: 11562065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dextromethorphan differentially affects opioid antinociception in rats.
    Chen SL; Huang EY; Chow LH; Tao PL
    Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of low-dose pentazocine on the development of antinociceptive tolerance to morphine.
    Chiba S; Hayashida M; Yoshikawa M; Shu H; Nishiyama T; Yamada Y
    J Anesth; 2009; 23(1):99-107. PubMed ID: 19234831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
    Pakarinen ED; Woods JH; Moerschbaecher JM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):552-9. PubMed ID: 7853168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.
    Wong CS; Hsu MM; Chou YY; Tao PL; Tung CS
    Br J Anaesth; 2000 Oct; 85(4):587-91. PubMed ID: 11064618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
    Lutfy K; Doan P; Nugyen M; Weber E
    Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
    Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
    J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 2016 May; 357(2):357-66. PubMed ID: 26937020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
    Gawel K; Jenda-Wojtanowska M; Gibula-Bruzda E; Kedzierska E; Filarowska J; Marszalek-Grabska M; Wojtanowski KK; Komsta L; Talarek S; Kotlinska JH
    Physiol Behav; 2018 Mar; 185():112-120. PubMed ID: 29294304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
    Le Guen S; Catheline G; Besson JM
    Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain.
    Mao J; Price DD; Mayer DJ
    Pain; 1995 Jun; 61(3):353-364. PubMed ID: 7478678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
    Kozela E; Pilc A; Popik P
    Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice.
    Belozertseva IV; Bespalov AYu
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):270-4. PubMed ID: 9750014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of kappa opioid receptors in the inhibition of receptor desensitization and PKC activation induced by repeated morphine treatment.
    Hamabe W; Yamane H; Harada S; Tokuyama S
    J Pharm Pharmacol; 2008 Sep; 60(9):1183-8. PubMed ID: 18718122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
    Tiseo PJ; Inturrisi CE
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.